SBC Medical Group Holdings Incorporated
SBC
$4.02
-$0.42-9.46%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
---|---|---|---|---|---|
Revenue | -28.76% | 12.28% | 29.51% | 27.72% | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -28.76% | 12.28% | 29.51% | 27.72% | |
Cost of Revenue | -44.43% | -28.55% | 50.71% | 6.19% | |
Gross Profit | -21.89% | 29.08% | 23.48% | 38.59% | |
SG&A Expenses | -28.88% | 121.05% | -26.02% | -13.27% | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | 82.45% | -37.20% | -6.80% | -47.89% | |
Total Operating Expenses | -35.76% | 44.01% | 1.50% | -4.67% | |
Operating Income | -17.56% | -30.91% | 75.27% | 120.82% | |
Income Before Tax | -74.29% | -37.79% | 62.49% | 121.61% | |
Income Tax Expenses | -105.23% | -21.05% | 25.16% | 44.31% | |
Earnings from Continuing Operations | -53.98% | -64.82% | 88.30% | 192.15% | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -107.73% | -100.54% | -108.96% | 101.81% | |
Net Income | -54.41% | -66.10% | 73.25% | 212.50% | |
EBIT | -17.56% | -30.91% | 75.27% | 120.82% | |
EBITDA | -22.00% | -36.28% | 46.67% | 83.64% | |
EPS Basic | -58.24% | -66.40% | 73.25% | -- | |
Normalized Basic EPS | -18.56% | -36.85% | 50.07% | -- | |
EPS Diluted | -18.12% | -66.40% | 73.25% | -- | |
Normalized Diluted EPS | -18.56% | -36.85% | 50.07% | -- | |
Average Basic Shares Outstanding | 9.09% | 0.96% | 0.00% | -- | |
Average Diluted Shares Outstanding | 9.09% | 0.96% | 0.00% | -- | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |